On January 24, 2025, Aimed Alliance submitted a comment to the Virginia House Appropriations – Health and Human Resources Subcommittee, urging them to reconsider VA HB 1724 and instead pursue legislation that directly reduces health care costs for consumers.
Aimed Alliance’s comment highlighted concerns with prescription drug affordability boards (PDABs), noting that upper payment limits (UPLs) control what payers reimburse pharmacy benefit managers (PBMs), not what patients pay. Additionally, the comment highlighted that there are no requirements to ensure any savings are passed on to consumers. The comment also emphasized that PDABs are experimental initiatives with significant upfront costs and no guarantee that any cost savings will ultimately reduce expenses for health care consumers or the state.
Aimed Alliance recommended alternative solutions, such as PBM reform to increase transparency in pharmacy steering, drug pricing, and rebate pass-throughs. Read the comment here.
Last Updated on February 25, 2025 by Aimed Alliance
